Evidence map›Paper›PMID 41129031›Full record

ArticleJournal of neuro-oncology2025

SUV-max of

Leihao Ren, Jiaojiao Deng, Juefeng Xu, Louman Chan, Qing Xie, Hiroaki Wakimoto, Ye Gong, Lingyang Hua

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Correlation of [EJNMMI research · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Leihao Ren *Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Jiaojiao Deng *Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Juefeng Xu *Department of Operation Center, Huashan Hospital, Fudan University, Shanghai, China.
Louman Chan *Department of Radiation Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China.
Qing XieDepartment of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Hiroaki WakimotoDepartment of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Ye Gong *Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Lingyang Hua *Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. hua.ling.yang@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodsWe conducted a retrospective study at a single neurosurgical center. Semiquantitative indices of

resultsEighty patients were retrospectively analyzed, including 45 with WHO grade 1 meningiomas, 33 with grade 2, and 2 with grade 3. The median SUV-max value was significantly higher in meningiomas with high WHO grade (P = 0.017), positive SSTR2a expression (P = 0.023), and in male patients (P = 0.002). Bulk RNA data was available in forty patients. RNA expression of SSTR2 was significantly elevated in the SSTR2a-positive group and correlated positively with SUV-max, SUV-median, and SUV-mean. Furthermore, the high RNA scores risk group exhibited significantly higher SUV-max compared to the intermediate- and low-risk groups. Of note, an SUV-max > 15.55 (P = 0.014) was independently associated with high WHO grade. Lastly, a nomogram incorporating SUV-max, gender, and surgical history demonstrated robust performance in preoperatively identifying patients at risk for high WHO grade, offering the potential utility of

conclusionSUV-max of

Indexed as

Meningeal NeoplasmsMeningiomaOrganometallic CompoundsPositron Emission Tomography Computed TomographyAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedNeoplasm GradingRadiopharmaceuticalsReceptors, SomatostatinRetrospective StudiesRNAgallium Ga 68 dotatateOrganometallic CompoundsRadiopharmaceuticalsReceptors, SomatostatinRNADOTATATEMeningiomaNomogramWHO grade

Identifiers

PMID41129031

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.